Loading…
Aimei Health Technology Co., Ltd is projected to decline to $11.88 by 2027, a -2% move from its current price of $12.13. AFJK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $11.38 | $12.12 | $12.92 | -0.02% |
| Aug 6 | $11.08 | $12.12 | $13.26 | -0.03% |
| Aug 7 | $10.86 | $12.12 | $13.53 | -0.05% |
| Aug 8 | $10.67 | $12.12 | $13.76 | -0.06% |
| Aug 9 | $10.51 | $12.12 | $13.96 | -0.08% |
| Aug 10 | $10.37 | $12.11 | $14.15 | -0.09% |
| Aug 11 | $10.24 | $12.11 | $14.33 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.24 | $12.11 | $14.33 | -0.11% |
| Week 2 | $9.54 | $12.10 | $15.34 | -0.22% |
| Week 3 | $9.03 | $12.09 | $16.17 | -0.33% |
| Week 4 | $8.63 | $12.07 | $16.89 | -0.44% |
| Week 5 | $8.28 | $12.06 | $17.56 | -0.55% |
| Week 6 | $7.98 | $12.05 | $18.18 | -0.66% |
| Week 7 | $7.71 | $12.03 | $18.77 | -0.76% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aimei Health Technology Co., Ltd is classified in Financial Services. The company currently has limited operations and is focused on pursuing a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors.
Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York. The company description aligns with its stated aim to pursue strategic opportunities in related sectors, without significant ongoing operations at this time.
AFJK is trading as a financial services stock with a current price of $11.80 and a market capitalization of $37.36M.
The year-by-year forecast shows a mixed path through the near term and a notable shift to stronger upside in the longer term. In 2026 the average price is $11.80 with a max of $16.56 and a min of $11.69, yielding 0% ROI and a NEUTRAL sentiment. The model projects ongoing variability, with later years turning bullish starting in 2034 and continuing into the 2040s and 2050s.
A major floor 3.6% below — a decisive break under it would weaken the trend.
The nearest floor, 3.6% below — buyers have tended to step in here.
The nearest ceiling, 180.6% above — a clean break opens room to run.
A major ceiling 459.7% above — clearing it would confirm fresh momentum.
Key AFJK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AFJK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.96 | Buy | $11.99 | Buy |
| MA 10 | $11.92 | Buy | $12.49 | Sell |
| MA 20 | $14.26 | Sell | $15.40 | Sell |
| MA 50 | $27.22 | Sell | $23.64 | Sell |
| MA 100 | $32.32 | Sell | $29.09 | Sell |
| MA 200 | $32.99 | Sell | $29.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 24.04 | Buy |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -39.03 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.74 | Buy |
| ROC (12) | 2.03 | Buy |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -3.24 | Sell |
| Awesome (5,34) | -8.90 | Sell |
| Ultimate (7,14,28) | 45.90 | Neutral |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 12.00 | Buy |
| ADX (14) | 45.65 | Sell |
| ATR (14) | 0.84 | Info |
Technically, the sentiment is NEUTRAL with RSI14 at 20, indicating a relatively oversold condition within the current framework. The 50-day simple moving average is $34.61 and the 200-day simple moving average is $32.95, showing a long-term view that is structurally higher than the near-term price level.
Near-term support is listed at $11.69 and resistance at $43.00, with the 30-day price range stretching from a low of $6.46 to a high of $21.56. These levels frame a volatile short-term picture, consistent with the high annualized volatility figure of 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.69 | $12.13 | $17.33 | 0% | Neutral | |
| $8.66 | $11.88 | $17.62 | -2% | Neutral | |
| $7.36 | $10.74 | $17.00 | -11% | Neutral | |
| $6.97 | $10.71 | $17.81 | -12% | Neutral | |
| $5.44 | $8.78 | $15.20 | -28% | Bearish | |
| $6.35 | $10.71 | $19.19 | -12% | Neutral | |
| $7.71 | $13.57 | $25.08 | +12% | Neutral | |
| $7.32 | $13.40 | $25.48 | +11% | Neutral | |
| $8.32 | $15.86 | $30.91 | +31% | Bullish | |
| $7.57 | $14.99 | $29.89 | +24% | Bullish | |
| $9.60 | $21.34 | $46.80 | +76% | Bullish | |
| $13.10 | $29.11 | $66.95 | +140% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $11.69 | $12.13 | $15.46 | +0.00% |
| September 2026 | $9.95 | $12.09 | $15.33 | -0.28% |
| October 2026 | $9.70 | $11.95 | $15.47 | -1.14% |
| November 2026 | $10.22 | $12.74 | $16.75 | +6.56% |
| December 2026 | $10.31 | $12.99 | $17.33 | +1.99% |
Click any year to see its month-by-month AFJK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AFJK could reach as high as $17.33, with a base case around $12.13 and support toward $11.69 — roughly 0% from $12.13. A consolidation phase looks the most probable path here.
Expect AFJK to range from $8.66 to $17.62 through 2027. The $11.88 average target implies a -2% move from current prices. That is -2% versus the projected 2026 average. Price action looks broadly range-bound.
The AFJK price prediction for 2028 points to an average of $10.74 (low $7.36, high $17.00) — a potential decline of -11% on today's $12.13. A consolidation phase looks the most probable path here.
In 2029, AFJK is projected to trade between $6.97 and $17.81, averaging $10.71 — a potential decline of -12% from today's $12.13. That is 0% versus the projected 2028 average. Price action looks broadly range-bound.
Aimei Health Technology Co., Ltd's 2030 outlook centres on $8.78, within a $5.44 to $15.20 range. That is -18% versus the projected 2029 average. That marks a -28% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2031, AFJK could reach as high as $19.19, with a base case around $10.71 and support toward $6.35 — roughly -12% from $12.13. Price action looks broadly range-bound.
Expect AFJK to range from $7.71 to $25.08 through 2032. The $13.57 average target implies a +12% move from current prices. That is up +27% on the projected 2031 average. A consolidation phase looks the most probable path here.
The AFJK price prediction for 2033 points to an average of $13.40 (low $7.32, high $25.48) — a potential gain of +11% on today's $12.13. Price action looks broadly range-bound.
In 2034, AFJK is projected to trade between $8.32 and $30.91, averaging $15.86 — a potential gain of +31% from today's $12.13. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Aimei Health Technology Co., Ltd's 2035 outlook centres on $14.99, within a $7.57 to $29.89 range. That is -6% versus the projected 2034 average. That marks a +24% change versus current levels. Momentum favours further upside here.
By 2040, AFJK could reach as high as $46.80, with a base case around $21.34 and support toward $9.60 — roughly +76% from $12.13. Buyers look set to stay in control over this stretch.
Expect AFJK to range from $13.10 to $66.95 through 2050. The $29.11 average target implies a +140% move from current prices. That is up +36% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in AFJK today (≈ 82.474227 AFJK) could be worth
$2,400.61
+$1,400.61 (+140%) by 2050 · US Dollar
Based on the average projected AFJK price of $29.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AFJKwould be worth at today's price.
$1,000 invested in AFJK on Jul 31, 2025 (≈ 88.495574 AFJK) would be worth
$1,073.01
+$73.01 (+7.3%) today · 1.07× · US Dollar
Based on a AFJK entry price of $11.3 vs. today's $12.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.76 | $1,031.04 | +3.1% |
| 1 month ago | $26.41 | $459.11 | -54.1% |
| 3 months ago | $46.18 | $262.56 | -73.7% |
| 6 months ago | $53.75 | $225.58 | -77.4% |
| 1 year ago | $11.3 | $1,073.01 | +7.3% |
| All time (2.5y) ago | $10.15 | $1,194.58 | +19.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AFJK forecast.
Our base-case forecast reaches $24.00 around 2050.
Implied market cap at $24.00: $75.99M
The multi-year forecast shows a clear turnaround from bearish to bullish momentum in the longer horizon. The 2029 forecast sits at an avg price of $10.02 with a max of $16.70 and ROI of -15.1%, presenting a Bearish sentiment. By 2032 the avg rises to $12.82 with an ROI of 8.6%, and by 2033 the avg reaches $13.38 with an ROI of 13.4%.
A stronger uptrend appears in 2034 with an avg of $15.78 and an ROI of 33.7%, followed by a continued bullish trajectory into 2040 where the avg is $21.10 and ROI reaches 78.8% (max $46.31). The long-range view culminates in 2050 with an avg of $27.18, a max of $62.50, and an ROI of 130.3%, with a Bullish sentiment indicated for those later years.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $5.51, an avg of $8.91, and a max of $15.45, with ROI -24.5% and sentiment BEARISH.
The near-term view is NEUTRAL, with 2026 showing an avg of $11.80 and ROI 0%, and the risk of further declines into 2029. Long term, the forecast turns bullish in 2034 and again in 2040 and 2050, with higher potential returns (e.g., 2034 ROI 33.7%, 2040 ROI 78.8%, 2050 ROI 130.3%), but these come with inherent uncertainty.
Yes. The 30-day technical resistance is $43.00, and the forecast max price reaches $46.31 in 2040, which implies $43 is within the modeled upper bound by 2040.
The current price is $11.80 and the market capitalization is $37.36M.
The 30-day range is $6.46 to $21.56, with support at $11.69 and resistance at $43.00. RSI14 is 20, the SMA50 is $34.61, the SMA200 is $32.95, and annualized volatility is 200%.
Aimei Health Technology Co., Ltd Community Discussion
0Share your Aimei Health Technology Co., Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.